Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Delayed Hypersensitivity

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Delayed Hypersensitivity in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saxena, HM1
Dikshit, M1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Delayed Hypersensitivity

ArticleYear
Abrogation of DTH response and mitogenic lectin- and alloantigen-induced activation of lymphocytes by calcium inhibitors TMB-8 and BAPTA-AM.
    Immunology letters, 2005, Oct-15, Volume: 101, Issue:1

    Topics: Animals; Calcium Channel Blockers; Chelating Agents; Concanavalin A; Egtazic Acid; Gallic Acid; Hype

2005